Industry News
DARA Receives US FDA Fast Track Designation For KRN5500
Aug 19, 2011
DARA BioSciences, Inc. (NASDAQ: DARA) announced that its investigational drug KRN5500 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of chemotherapy-induced neuropathic pain in patients with cancer... Read More
Cancer Stem Cells Made, Not Born
Aug 19, 2011
In cancer, tumors aren't uniform: they are more like complex societies, each with a unique balance of cancer cell types playing different roles. Understanding this "social structure" of tumors is critical for treatment decisions in the clinic because different cell types may be sensitive to different drugs... Read More
Generex Subsidiary Antigen Express Provides Update On Phase 2 Breast Cancer Immunotherapy Program
Aug 19, 2011
Generex Biotechnology Corporation (OTCBB: GNBT) announced that the Company's wholly-owned subsidiary Antigen Express, Inc... Read More
New Drug In Early Clinical Testing Offers New Hope For Treatment Of Chronic Leukemia
Aug 19, 2011
While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment. This information was released in the online edition of Blood, a weekly medical journal published by the American Society of Hematology... Read More
Lung Cancer Risk Greater With Certain Gene Combination, Particularly In Light Smokers
Aug 19, 2011
Smokers with variations in two specific genes have a greater risk of smoking more cigarettes, becoming more dependent on nicotine and developing lung cancer, a new study from the Centre for Addiction and Mental Health (CAMH) shows... Read More
Major Advanced Cancer Study To Be Led By Uppsala University
Aug 19, 2011
Several prominent cancer researchers are now joining forces in an advanced new cancer study. The goal is to understand which tumors will be difficult to treat and to find out why certain cancer drugs lose their effect after a period of use. The study is to be directed by Tobias Sjöblom, associate professor of tumor biology at Uppsala University, Sweden... Read More
FDA Approval For Ovarian And Breast Cancer Vaccines Received By Mayo Clinic
Aug 19, 2011
Mayo Clinic has received investigational new drug approval* from the Food and Drug Administration for two new cancer vaccines that mobilize the body's defense mechanisms to destroy malignant cells. The vaccines are among the first aimed at preventing cancer recurrence. The approval clears the way for Phase I clinical trials with women treated for ovarian or breast cancer... Read More
Superficial Vein Thrombosis Increases Risk For Developing Life-Threating Blood Clots
Aug 19, 2011
Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood, the Journal of the American Societ... Read More
Melamona Drug Zelboraf Approved By US FDA
Aug 19, 2011
Yesterday the U.S. Food and Drug Administration approved Zelboraf (venurafenib), a medicine to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous form of skin cancer... Read More
The Scent Of Lung Cancer Recognized By Sniffer Dogs
Aug 19, 2011
Sniffer dogs could be used for the early detection of lung cancer, according to new research published in the European Respiratory Journal. The study, carried out by researchers from Schillerhoehe Hospital in Germany, is the first to find that sniffer dogs can reliably detect lung cancer... Read More
Previous Page Next Page